Latest IR information
IR News
- 2025.06.30
- SymBio Submits Clinical Trial Application for a Phase 3 Global Study Evaluating IV Brincidofovir for the Treatment of Adenovirus Infection after HSCT
- 2025.06.18
- Comprehensive Review of the Development of Brincidofovir for Diverse Indications Published by Wiley
- 2025.06.10
- Revision to Earnings Forecast for FY 2025
- 2025.06.10
- SymBio Announces Enrollment of the First Patient in International Phase Ib/II Clinical Trial of IV Brincidofovir for Malignant Lymphoma
- 2025.05.16
- 株主通信「SymBio VISION vol.27」(Japanese only)